Results with SB 705498, a TRPV1 antagonist, suggest that such drugs could relieve the pain associated with inflammation and tissue injury

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1618, 2007-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TRPV1: On the Road to Pain Relief

By  

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 255-269

Bentham Science Publishers

Access to resources Recommend Favorite

Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade

By Lázár József   Gharat Laxmikant   Khairathkar-Joshi Neelima   Blumberg Peter M   Szallasi Arpad  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 2, 2009-02 ,pp. : 159-180

Informa Healthcare

Access to resources Recommend Favorite

Targeting TRPV1 for pain relief: limits, losers and laurels

By Szallasi Arpad   Sheta Mohamed  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1351-1369

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Development of Selective TRPV1 Antagonists for Pain

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1431-1441

Bentham Science Publishers

Access to resources Recommend Favorite

Leeches relieve pain in knee osteoarthritis

By  

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite